Related Experiment Video
Updated: May 24, 2026

Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil
Published on: January 4, 2014
[The Brazilian pharmaceutical industry and foreign trade: is there evidence of regressive specialization?]
Fábio Batista Mota1, José Eduardo Cassiolato, Carlos Augusto Grabois Gadelha
1Instituto de Economia, Universidade Federal do Rio de Janeiro, Av. Pasteur 250, Rio de Janeiro, RJ, Brazil. motafb@hotmail.com
Abstract:
Based on an exploratory discussion, the aim of this article is to investigate whether there is evidence of regressive specialization in the foreign trade pattern of the Brazilian pharmaceutical industry since trade liberalization in the 1990s. A descriptive statistical analysis drew on data for foreign trade in pharmaceutical and organic chemical products, available in the Aliceweb system of the Ministry of Development, Industry, and Foreign Trade, covering the periods 1989-1995 and 1996-2008. The results, especially concerning trends in Brazil's trade with developed countries, suggest evidence of regressive specialization.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Bioequivalence of Drugs: Drugs with Multiple Indications
Drug Regulation
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Production of Pharmaceuticals

